Perthera Inc. announced its partnership with Hope for Stomach Cancer, a patient-focused nonprofit that provides support, resources, and awareness to those facing stomach cancer. Perthera’s Precision Cancer Analysis service will be available to all Hope for Stomach Cancer patients at no cost to them.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
